Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The British Journal of Dermatology|December 21, 2012
Provoking factors, including chemicals, in Dutch patients with vitiligoC Vrijman, D Hosseinpour, J G Bakker, et al.
Human Antibodies|January 1, 1997
Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cellsR M Luiten, S O Warnaar, J Schuurman, et al.
The British Journal of Dermatology|August 7, 2012
The prevalence of thyroid disease in patients with vitiligo: a systematic reviewC Vrijman, M W Kroon, J Limpens, et al.
The British Journal of Dermatology|November 10, 2012
Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partnersH E Teulings, M Overkamp, E Ceylan, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2012
Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligoM W Kroon, E Helen Kemp, B S Wind, et al.
Immuno-Oncology Technology|December 19, 2024
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapyM Willemsen, J Bulgarelli, S K Chauhan, et al.
The British Journal of Dermatology|November 5, 2011
Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligoM W Kroon, I C K W Joore, B S Wind, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 20, 2019
Effect of immunosuppressive treatment on biomarkers in adult atopic dermatitis patientsE Roekevisch, K Szegedi, D P Hack, et al.
Pageof 3